These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33791735)

  • 1. Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19) Infection: Possible role for the NLRP3 inflammasome.
    Paul O; Tao JQ; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
    medRxiv; 2021 Mar; ():. PubMed ID: 33791735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19): Possible Role for the NLRP3 Inflammasome.
    Paul O; Tao JQ; West E; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
    Res Sq; 2021 Sep; ():. PubMed ID: 34494018
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome.
    Paul O; Tao JQ; West E; Litzky L; Feldman M; Montone K; Rajapakse C; Bermudez C; Chatterjee S
    Respir Res; 2022 Feb; 23(1):25. PubMed ID: 35144622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasome formation in the lungs of patients with fatal COVID-19.
    Toldo S; Bussani R; Nuzzi V; Bonaventura A; Mauro AG; Cannatà A; Pillappa R; Sinagra G; Nana-Sinkam P; Sime P; Abbate A
    Inflamm Res; 2021 Jan; 70(1):7-10. PubMed ID: 33079210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in the relationship between NLRP3 inflammasome and lung injury in COVID-19].
    Ren Z; Che P; Li Z; Mo M; Zhang S; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):844-850. PubMed ID: 34533131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.
    Konopka KE; Nguyen T; Jentzen JM; Rayes O; Schmidt CJ; Wilson AM; Farver CF; Myers JL
    Histopathology; 2020 Oct; 77(4):570-578. PubMed ID: 32542743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology.
    Morales L; Oliveros JC; Enjuanes L; Sola I
    mBio; 2022 Apr; 13(2):e0313521. PubMed ID: 35229638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin 1-7 Stimulates Proliferation of Lung Bronchoalveolar Progenitors-Implications for SARS-CoV-2 Infection.
    Ciechanowicz AK; Lay WX; Prado Paulino J; Suchocki E; Leszczak S; Leszczak C; Kucia M
    Cells; 2022 Jul; 11(13):. PubMed ID: 35805187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection.
    Roden AC; Bois MC; Johnson TF; Aubry MC; Alexander MP; Hagen CE; Lin PT; Quinton RA; Maleszewski JJ; Boland JM
    Arch Pathol Lab Med; 2021 Jan; 145(1):11-21. PubMed ID: 32821902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].
    Wu JH; Li X; Huang B; Su H; Li Y; Luo DJ; Chen S; Ma L; Wang SH; Nie X; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):568-575. PubMed ID: 32486534
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
    Rodrigues TS; de Sá KSG; Ishimoto AY; Becerra A; Oliveira S; Almeida L; Gonçalves AV; Perucello DB; Andrade WA; Castro R; Veras FP; Toller-Kawahisa JE; Nascimento DC; de Lima MHF; Silva CMS; Caetite DB; Martins RB; Castro IA; Pontelli MC; de Barros FC; do Amaral NB; Giannini MC; Bonjorno LP; Lopes MIF; Santana RC; Vilar FC; Auxiliadora-Martins M; Luppino-Assad R; de Almeida SCL; de Oliveira FR; Batah SS; Siyuan L; Benatti MN; Cunha TM; Alves-Filho JC; Cunha FQ; Cunha LD; Frantz FG; Kohlsdorf T; Fabro AT; Arruda E; de Oliveira RDR; Louzada-Junior P; Zamboni DS
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33231615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome activation in infected macrophages drives COVID-19 pathology.
    Sefik E; Qu R; Junqueira C; Kaffe E; Mirza H; Zhao J; Brewer JR; Han A; Steach HR; Israelow B; Blackburn HN; Velazquez S; Chen YG; Halene S; Iwasaki A; Meffre E; Nussenzweig M; Lieberman J; Wilen CB; Kluger Y; Flavell RA
    bioRxiv; 2022 Apr; ():. PubMed ID: 34611663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients.
    Beigmohammadi MT; Jahanbin B; Safaei M; Amoozadeh L; Khoshavi M; Mehrtash V; Jafarzadeh B; Abdollahi A
    Int J Surg Pathol; 2021 Apr; 29(2):135-145. PubMed ID: 32552178
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45
    Ratajczak MZ; Bujko K; Ciechanowicz A; Sielatycka K; Cymer M; Marlicz W; Kucia M
    Stem Cell Rev Rep; 2021 Feb; 17(1):266-277. PubMed ID: 32691370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
    Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
    J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
    Lara PC; Macías-Verde D; Burgos-Burgos J
    Aging Dis; 2020 Jul; 11(4):756-762. PubMed ID: 32765942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19: effects on the lungs and heart].
    Ackermann M; Werlein C; Länger F; Kühnel MP; Jonigk DD
    Pathologe; 2021 Mar; 42(2):164-171. PubMed ID: 33560456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.